| Application no. and date | 20884269.0 (espacenet) (Federated) (European Patent Register), 20201104 | | Patent/reg. no. and date | DK/EP 4054584, 20250709 | | Publication date | 20220914 | | Priority no. and date | US 201962930860 P, 20191105 | | EP pub. no. and date |
EP 4054584 20220914 | | Effective date | | | Applicant/owner | Resverlogix Corp., 300, 4820 Richard Road SW
Calgary, AB T3E 6L1, CA | | Applicant ref. no. | 24394DK00 | | Inventor | HALLIDAY, Christopher Ross Armstrong, 403 138 18 Avenue SE
Calgary, AB T2G 5P9, CA,
KHAN, Aziz Naeem, 317 - 5115 Richard Road SW
Calgary, AB T3E 7M7, CA,
LEBIODA, Kenneth Eugene, 216 Elbow Ridge Haven
Calgary, AB T3Z 3T2, CA | | Representative | Inspicos P/S, Strandvejen 60 , 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/70 (2006.01) , A61K 31/7042 (2006.01) , A61K 31/7048 (2006.01) , A61K 45/06 (2006.01) , A61P 9/00 (2006.01) , C07D 239/91 (2006.01) | | Title | Methods of treatment and/or prevention of major adverse cardiovascular events (MACE) with a combination of a BET bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor | | Int. application no. | IB2020000912 | | Int. publication no. | WO2021090061 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
